347 related articles for article (PubMed ID: 16549459)
1. High cholesterol intake modifies chylomicron metabolism in normolipidemic young men.
César TB; Oliveira MR; Mesquita CH; Maranhão RC
J Nutr; 2006 Apr; 136(4):971-6. PubMed ID: 16549459
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism.
Almeida KA; Schreiber R; Amâncio RF; Bydlowski SP; Debes-Bravo A; Issa JS; Strunz CM; Maranhão RC
Clin Chim Acta; 2003 Sep; 335(1-2):157-63. PubMed ID: 12927697
[TBL] [Abstract][Full Text] [Related]
3. Plasma kinetics of an artificial emulsion resembling chylomicrons in patients with chronic lymphocytic leukemia.
Sakashita AM; Bydlowski SP; Chamone DA; Maranhão RC
Ann Hematol; 2000 Dec; 79(12):687-90. PubMed ID: 11195006
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma.
Gonçalves RP; Hungria VT; Chiattone CS; Pozzi DB; Maranhão RC
Leuk Res; 2003 Feb; 27(2):147-53. PubMed ID: 12526920
[TBL] [Abstract][Full Text] [Related]
5. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease.
Maranhão RC; Feres MC; Martins MT; Mesquita CH; Toffoletto O; Vinagre CG; Gianinni SD; Pileggi F
Atherosclerosis; 1996 Sep; 126(1):15-25. PubMed ID: 8879430
[TBL] [Abstract][Full Text] [Related]
6. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease.
Sposito AC; Santos RD; Hueb W; Ventura LI; Vinagre CC; Ramires JA; Maranhão RC
Atherosclerosis; 2002 Apr; 161(2):447-53. PubMed ID: 11888530
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
[TBL] [Abstract][Full Text] [Related]
8. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
[TBL] [Abstract][Full Text] [Related]
9. Malignant hypertension is accompanied by marked alterations in chylomicron metabolism.
Bernardes-Silva H; Toffoletto O; Bortolotto LA; Latrilha MC; Krieger EM; Pileggi F; Maranhão RC
Hypertension; 1995 Dec; 26(6 Pt 2):1207-10. PubMed ID: 7498998
[TBL] [Abstract][Full Text] [Related]
10. Clearance of a chylomicron-like emulsion from plasma is delayed in patients with coronary artery disease.
Martins MC; Pileggi F; Maranhão RC
Braz J Med Biol Res; 1995 Apr; 28(4):427-31. PubMed ID: 8520539
[TBL] [Abstract][Full Text] [Related]
11. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
[TBL] [Abstract][Full Text] [Related]
12. Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease.
Sposito AC; Ventura LI; Vinagre CG; Lemos PA; Quintella E; Santos RD; Carneiro O; Ramires JA; Maranhão RC
Atherosclerosis; 2004 Oct; 176(2):397-403. PubMed ID: 15380465
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a cholesteryl ester donor activity of LDL particles during alimentary lipemia in normolipidemic subjects.
Lassel TS; Guerin M; Auboiron S; Guy-Grand B; Chapman MJ
Atherosclerosis; 1999 Nov; 147(1):41-8. PubMed ID: 10525123
[TBL] [Abstract][Full Text] [Related]
14. Relationships in women between body mass index and the intravascular metabolism of chylomicron-like emulsions.
Oliveira MR; Maranhão RC
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1471-8. PubMed ID: 15486570
[TBL] [Abstract][Full Text] [Related]
15. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: study with artificial emulsions.
Carneiro MM; Miname MH; Gagliardi AC; Pereira C; Pereira AC; Krieger JE; Maranhão RC; Santos RD
Atherosclerosis; 2012 Mar; 221(1):268-74. PubMed ID: 22257824
[TBL] [Abstract][Full Text] [Related]
16. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease.
Santos RD; Sposito AC; Ventura LI; Cesar LA; Ramires JA; Maranhão RC
Am J Cardiol; 2000 May; 85(10):1163-6. PubMed ID: 10801994
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins.
Sposito AC; Santos RD; Amâncio RF; Ramires JA; Chapman MJ; Maranhão RC
Atherosclerosis; 2003 Feb; 166(2):311-21. PubMed ID: 12535744
[TBL] [Abstract][Full Text] [Related]
18. Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits.
Ross AC; Zilversmit DB
J Lipid Res; 1977 Mar; 18(2):169-81. PubMed ID: 191549
[TBL] [Abstract][Full Text] [Related]
19. Plasma kinetics of a chylomicron-like emulsion in normolipidemic obese women after a short-period weight loss by energy-restricted diet.
Oliveira MR; Maranhão RC
Metabolism; 2002 Sep; 51(9):1097-103. PubMed ID: 12200752
[TBL] [Abstract][Full Text] [Related]
20. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men.
Ginsberg HN; Karmally W; Siddiqui M; Holleran S; Tall AR; Rumsey SC; Deckelbaum RJ; Blaner WS; Ramakrishnan R
Arterioscler Thromb; 1994 Apr; 14(4):576-86. PubMed ID: 8148356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
